Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.
Quarterly Dividends Per Share
FRC
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2021
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
2022
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
2023
premium
Premium data
premium
Premium data
premium
Premium data
- -
- -
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Revenue per ShareRevenue per Share
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Basic EPS, GAAPBasic EPS, GAAP
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Free Cash Flow per Basic ShareFree Cash Flow per Basic Share
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Dividend per ShareDividend per Share
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Book Value per ShareBook Value per Share
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Tangible Book Value per ShareTangible Book Value per Share